Balu Balasubramanian

Discovery of a 1<i>H</i>-Benzoimidazol-2-yl)-1<i>H</i>-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Mark D. Wittman, Joan M. Carboni, Ricardo M. Attar et al. · Journal of Medicinal Chemistry · 2005 · 134 citations · Full text

Pharmacotherapy, Insulin Receptor, Insulin Signaling +21

Sordarin Oxazepine Derivatives as Potent Antifungal Agents

Michael H. Serrano‐Wu, Denis R. St. Laurent, Yijun Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 56 citations

Medicinal Chemistry, Antifungal Agent, Sordarin Oxazepine Derivatives +5

Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile

Upender Velaparthi, Peiying Liu, Balu Balasubramanian et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 46 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

Byron H. Long, Balu Balasubramanian · Expert Opinion on Therapeutic Patents · 2000 · 43 citations

Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)

Upender Velaparthi, Mark D. Wittman, Peiying Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 40 citations · Full text

Medicinal Chemistry, Initial Sar, Biochemistry +6